QNRX – quoin pharmaceuticals, ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome [Yahoo! Finance]
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
Form 4 Quoin Pharmaceuticals, For: Mar 26 Filed by: Stonepine Capital Management, LLC
Form 10-K Quoin Pharmaceuticals, For: Dec 31
Form 8-K Quoin Pharmaceuticals, For: Mar 26
Form 8-K Quoin Pharmaceuticals, For: Mar 11
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: ADAR1 Capital Management, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.